• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型干扰素作用于肺泡巨噬细胞以促进病毒感染后的细菌性肺炎。

Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection.

作者信息

Palani Sunil, Uddin Md Bashir, McKelvey Michael, Shao Shengjun, Wu Wenzhe, Bao Xiaoyong, Sun Jiaren, Sun Keer

机构信息

The University of Texas Medical Branch at Galveston, Galveston, Texas, United States.

Sylhet Agricultural University, Sylhet, Sylhet Division, Bangladesh.

出版信息

Am J Respir Cell Mol Biol. 2025 Jan 29. doi: 10.1165/rcmb.2024-0552OC.

DOI:10.1165/rcmb.2024-0552OC
PMID:39879546
Abstract

Exposure to influenza A virus (IAV), respiratory syncytial virus (RSV), and human metapneumovirus (hMPV) is well-known to increase the risk of pneumonia in humans. Type I interferon (IFN-I) is a hallmark response to acute viral infections, and alveolar macrophages (AMs) constitute the first line of airway defense against opportunistic bacteria. Our study reveals that virus-induced IFN-I receptor (IFNAR1) signaling directly impairs AM-dependent antibacterial protection. Using conditional knockout mouse models, in vivo antibodies, bone marrow chimeric mice, and AM reconstitution, we demonstrate that IFN-I intrinsically targets AMs to drive hypersusceptibility to following IAV infection. Importantly, we show that RSV and hMPV infection induces robust IFN-I signaling in AMs, coinciding with lethal susceptibility to secondary pneumonia. In contrast, seasonal human coronavirus neither induces significant IFN-I signaling in AMs nor immune predisposition to . Therefore, we conclude that IFN-I inhibition of AMs represents a crucial mechanism underlying antibacterial complications following otherwise asymptomatic or mild respiratory viral infections.

摘要

众所周知,感染甲型流感病毒(IAV)、呼吸道合胞病毒(RSV)和人偏肺病毒(hMPV)会增加人类患肺炎的风险。I型干扰素(IFN-I)是对急性病毒感染的标志性反应,而肺泡巨噬细胞(AM)构成了抵御机会性细菌的气道第一道防线。我们的研究表明,病毒诱导的I型干扰素受体(IFNAR1)信号直接损害AM依赖的抗菌保护作用。利用条件性敲除小鼠模型、体内抗体、骨髓嵌合小鼠和AM重建,我们证明IFN-I内在地靶向AM,导致IAV感染后对继发性肺炎的易感性增加。重要的是,我们发现RSV和hMPV感染在AM中诱导强烈的IFN-I信号,这与对继发性肺炎的致命易感性相一致。相比之下,季节性人类冠状病毒既不会在AM中诱导显著的IFN-I信号,也不会导致对继发性肺炎的免疫易感性。因此,我们得出结论,IFN-I对AM的抑制作用是无症状或轻度呼吸道病毒感染后抗菌并发症的关键机制。

相似文献

1
Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection.I型干扰素作用于肺泡巨噬细胞以促进病毒感染后的细菌性肺炎。
Am J Respir Cell Mol Biol. 2025 Jan 29. doi: 10.1165/rcmb.2024-0552OC.
2
Type I Interferon, Induced by Adenovirus or Adenoviral Vector Infection, Regulates the Cytokine Response to Lipopolysaccharide in a Macrophage Type-Specific Manner.由腺病毒或腺病毒载体感染诱导产生的I型干扰素,以巨噬细胞类型特异性方式调节对脂多糖的细胞因子反应。
J Innate Immun. 2024;16(1):226-247. doi: 10.1159/000538282. Epub 2024 Mar 25.
3
Absence of c-Maf and IL-10 enables type I IFN enhancement of innate responses to LPS in alveolar macrophages.c-Maf和白细胞介素-10的缺失使得I型干扰素增强肺泡巨噬细胞对脂多糖的天然免疫反应。
J Immunol. 2025 Mar 3;214(3):551-64. doi: 10.1093/jimmun/vkae029.
4
Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.在缺乏I型干扰素的情况下,肺泡巨噬细胞可控制呼吸道合胞病毒感染。
J Innate Immun. 2016;8(5):452-63. doi: 10.1159/000446824. Epub 2016 Jul 16.
5
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
6
Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.肺泡巨噬细胞有助于人类偏肺病毒感染的发病机制,同时能预防呼吸道合胞病毒感染。
Am J Respir Cell Mol Biol. 2014 Oct;51(4):502-15. doi: 10.1165/rcmb.2013-0414OC.
7
Elimination of gut microbiota hinders the therapeutic effect of amentoflavone on respiratory syncytial virus-induced lung inflammation injury by regulating innate immunity.消除肠道微生物群会通过调节先天免疫来阻碍穗花杉双黄酮对呼吸道合胞病毒诱导的肺部炎症损伤的治疗效果。
Phytomedicine. 2025 Jul 8;145:157033. doi: 10.1016/j.phymed.2025.157033.
8
Zika virus-induced fetal demise is triggered by strain- and dose-specific RLR-driven activation of the interferon response in the decidua, placenta, and fetus in mice.寨卡病毒诱导的胎儿死亡是由小鼠蜕膜、胎盘和胎儿中视黄酸诱导基因样受体(RLR)驱动的、特定毒株和剂量的干扰素反应激活所引发的。
J Virol. 2025 May 22:e0066625. doi: 10.1128/jvi.00666-25.
9
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease.SARS-CoV-2 感染后肺泡巨噬细胞中的抗病毒先天免疫记忆可改善二次甲型流感病毒疾病。
Immunity. 2024 Nov 12;57(11):2530-2546.e13. doi: 10.1016/j.immuni.2024.08.018. Epub 2024 Sep 30.
10
CYP1B1 knockout enhanced IFN-γ production is required but not sufficient for protection of cigarette smoke-exposed mice against lethal influenza virus infection.CYP1B1基因敲除增强的γ干扰素产生对于保护暴露于香烟烟雾的小鼠免受致死性流感病毒感染是必需的,但并不充分。
Front Immunol. 2025 Jul 4;16:1600025. doi: 10.3389/fimmu.2025.1600025. eCollection 2025.

引用本文的文献

1
A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA-PB1 interactions and modulating host macrophage inflammation.一种新型的C-3-取代齐墩果酸苄基酰胺衍生物通过靶向PA-PB1相互作用和调节宿主巨噬细胞炎症,展现出抗甲型流感的治疗潜力。
Acta Pharm Sin B. 2025 Aug;15(8):4156-4173. doi: 10.1016/j.apsb.2025.05.031. Epub 2025 May 29.
2
Epigenetic changes and serotype-specific responses of alveolar type II epithelial cells to Streptococcus pneumoniae in resolving influenza A virus infection.在甲型流感病毒感染消退过程中,肺泡II型上皮细胞对肺炎链球菌的表观遗传变化和血清型特异性反应。
Cell Commun Signal. 2025 Jun 12;23(1):278. doi: 10.1186/s12964-025-02284-y.
3
(Inter)feron the Reaper: New Insights on an Old Cytokine in Secondary Bacterial Pneumonia.
(间)干扰素——“死神”:对继发性细菌性肺炎中一种古老细胞因子的新见解
Am J Respir Cell Mol Biol. 2025 Aug;73(2):166-167. doi: 10.1165/rcmb.2025-0026ED.